The conservative Core / Flex approach has been working well in recent years. Still a work in progress, but it sure beats the 'bad old days' of biotech :o)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.